Luckbox Leans in with Mark Cuban
By James Melton
Cost Plus Drugs Company is selling prescription medications at dramatically low prices
What would happen if drug pricing made sense to consumers?
Mark Cuban Cost Plus Drug Company, which launched its online pharmacy about a year ago, is trying to answer that question. Its approach is easy to understand—even if it’s difficult to implement.
First, CPD negotiates directly with manufacturers to get the best possible price. It adds a 15% markup based on the per-pill price that CPD pays to buy the medicines. Then, CPD adds a flat $3 pharmacy labor fee and $5 standard shipping to get to the total retail price.
Cuban believes strongly in CPD’s mission and business model. Among his many ventures, this is the first company to...
Topics
-
How Much Do Moats Matter?
By Ed McKinley
|While Buffett and Musk disagree, a company’s value can reside in its surrounding protective barrier -
Will America Issue a Central Bank Digital Currency?
By Ed McKinley
|Reactions to CBDC range from indifference to alarm -
CoreWeave: Poised to Transform AI
|CoreWeave, a Nvidia-backed pioneer of cloud services for artificial intelligence, is preparing for an IPO -
How Much Does the U.S. Really Spend on NATO and Foreign Aid?
By Ed McKinley
|The U.S. is paying less than you might think to defend Europe, and NATO members are stepping up their contributions -
$4.4 Billion Has Been Spent on This Election
By Ed McKinley
|Everybody follows presidential fundraising, but who knows where all that cash goes? -
An All-Star Panel Wades Into the Election Prediction Market Trading Pits
By Jeff Joseph
|Mark Cuban, Robert Cahaly, and others joined Luckbox’s Jeff Joseph to look several days into the future without the advantage of a crystal ball -
What’s Driving Luckbox Readers to the Voting Booth?
|Our most recent survey reveals the political thinking of our favorite group of investors -
Predicting the Unpredictable: Early Voting, Swing States and the Road to 270
|With early voting trends pointing to fresh records, the result of the 2024 presidential election will likely be once again decided by a handful of key swing states. -
Alex Karp: Meet the Self-Described Freak Leading the S&P 500’s Newest Member
By Ed McKinley
|The Palantir Technologies CEO does things his way—and it works -
What’s Driving the Price of Gold?
By Ed McKinley
|The upward pressure has resulted from economic uncertainty, stockpiling by central banks and wars raging on two continents. But will the trend remain intact? -
Why I Just Bought More Gold Bullion
|They're debasing the currency—and monetary inflation is rising with liquidity -
How Are Luckbox Readers Voting?
|You told us in our recent reader's survey. Here’s a summary of where you stand compared with recent results from national polls. -
Big Crypto’s Campaign Cash
By Ed McKinley
|Two companies have opened up their crypto wallets to lead the corporate sector in 2024 election campaign contributions -
Trump Trade 2.0: The Energy Sector Would Benefit if Trump Regains the White House
|Meanwhile, the ups and downs of Trump Media & Technology Group (DJT) stock provide a campaign barometer -
Economics Scorecard: Trump vs. Biden
|Despite differing politics and policies, the economic records of the two presidents share a common theme: resilience -
Who is Hindenburg Research?
By Ed McKinley
|The short-seller turns a profit by ferreting out corporate wrongdoing. Just ask Carl Icahn. -
From SoundHound to Lemonade: Top Small-Cap AI Stocks to Watch in 2024
|Smaller firms could be the next wave of winners in the artificial intelligence race -
Is BlackRock Really Buying Up Homes?
By Ed McKinley
|Yes, the giant institutional investor is acquiring them by the tens of thousands -
The Housing Affordability Crisis Hits Home for Young Adults
By Ed McKinley
|Despite the Fed's recent cut in interest rates, owning a house or condo still seems like an unattainable dream for many young Americans